In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Genetically Engineered Food Right-
to-Know Act''.

SEC. 2. PURPOSE AND FINDINGS.

    (a) Purpose.--The purpose of this Act is to establish a consistent 
and enforceable standard for labeling of foods produced using genetic 
engineering, including fish, thereby providing consumers with knowledge 
of how their food is produced.
    (b) Findings.--Congress finds that--
            (1) the process of genetically engineering food organisms 
        results in material changes to food derived from those 
        organisms;
            (2) the Food and Drug Administration requires the labeling 
        of more than 3,000 ingredients, additives, and processes;
            (3) individuals in the United States have a right to know 
        if their food was produced with genetic engineering for a 
        variety of reasons, including health, economic, environmental, 
        religious, and ethical;
            (4) more than 60 countries, including the United Kingdom 
        and all other countries of the European Union, South Korea, 
        Japan, Brazil, Australia, India, China, and other key United 
        States trading partners have laws or regulations mandating 
        disclosure of genetically engineered food on food labels;
            (5) in 2011, Codex Alimentarius, the food standards 
        organization of the United Nations, adopted a text that 
        indicates that governments can decide on whether and how to 
        label foods produced with genetic engineering; and
            (6) mandatory identification of food produced with genetic 
        engineering can be a critical method of preserving the economic 
        value of exports or domestically sensitive markets with 
        labeling requirements for genetically engineered foods.

SEC. 3. AMENDMENTS TO THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.

    (a) In General.--Section 403 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 343) is amended by adding at the end the 
following:
    ``(z)(1) If it is a food that has been genetically engineered or 
contains 1 or more genetically engineered ingredients, unless such 
information is clearly disclosed, as determined by the Secretary.
    ``(2) This paragraph does not apply to food that--
            ``(A) is served in restaurants or other similar eating 
        establishments, such as cafeterias and carryouts;
            ``(B) is a medical food (as defined in section 5(b) of the 
        Orphan Drug Act);
            ``(C) is a food that would be subject to this paragraph 
        solely because it was produced using a genetically engineered 
        vaccine; or
            ``(D) is a food or processed food that would be subject to 
        this paragraph solely because it includes the use of a 
        genetically engineered processing aid (including yeast) or 
        enzyme.
    ``(3) In this paragraph:
            ``(A) The term `genetic engineering' means a process 
        involving the application of--
                    ``(i) in vitro nucleic acid techniques, including 
                recombinant deoxyribonucleic acid (DNA) and direct 
                injection of nucleic acid into cells or organelles; or
                    ``(ii) fusion of cells beyond the taxonomic family 
                that--
                            ``(I) overcome natural physiological 
                        reproductive or recombinant barriers; and
                            ``(II) are not techniques used in 
                        traditional breeding and selection.
            ``(B) The term `genetically engineered', used with respect 
        to a food, means a material intended for human consumption that 
        is--
                    ``(i) an organism that is produced through the 
                intentional use of genetic engineering; or
                    ``(ii) the progeny of intended sexual or asexual 
                reproduction (or both) of 1 or more organisms that is 
                the product of genetic engineering.
            ``(C) The term `genetically engineered ingredient' means a 
        material that is an ingredient in a food that is derived from 
        any part of an organism that has been genetically engineered, 
        without regard to whether--
                    ``(i) the altered molecular or cellular 
                characteristics of the organism are detectable in the 
                material; and
                    ``(ii) the organism is capable for use as human 
                food.''.
    (b) Guaranty.--
            (1) In general.--Section 303(d) of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 333(d)) is amended--
                    (A) by striking ``(d)'' and inserting ``(d)(1)''; 
                and
                    (B) by adding at the end the following:
            ``(2)(A) No person shall be subject to the penalties of 
        subsection (a)(1) for a violation of subsection (a), (b), or 
        (c) of section 301 involving food that is misbranded within the 
        meaning of section 403(z) if such person (referred to in this 
        paragraph as the `recipient') establishes a guaranty or 
        undertaking that--
                    ``(i) is signed by, and contains the name and 
                address of, a person residing in the United States from 
                whom the recipient received in good faith the food 
                (including the receipt of seeds to grow raw 
                agricultural commodities); and
                    ``(ii) contains a statement to the effect that the 
                food is not genetically engineered or does not contain 
                a genetically engineered ingredient.
            ``(B) In the case of a recipient who, with respect to a 
        food, establishes a guaranty or undertaking in accordance with 
        subparagraph (A), the exclusion under such subparagraph from 
        being subject to penalties applies to the recipient without 
        regard to the manner in which the recipient uses the food, 
        including whether the recipient is--
                    ``(i) processing the food;
                    ``(ii) using the food as an ingredient in a food 
                product;
                    ``(iii) repacking the food; or
                    ``(iv) growing, raising, or otherwise producing the 
                food.
            ``(C) No person may avoid responsibility or liability for a 
        violation of subsection (a), (b), or (c) of section 301 
        involving food that is misbranded within the meaning of section 
        403(z) by entering into a contract or other agreement that 
        specifies that another person shall bear such responsibility or 
        liability, except that a recipient may require a guaranty or 
        undertaking as described in this subsection.
            ``(D) In this subsection, the terms `genetically 
        engineered' and `genetically engineered ingredient' have the 
        meanings given the terms in section 403(z).''.
            (2) False guaranty.--Section 301(h) of the Federal Food, 
        Drug, and Cosmetic Act (21 U.S.C. 331(h)) is amended by 
        inserting ``or 303(d)(2)'' after ``section 303(c)(2)''.
    (c) Unintended Contamination.--Section 303(d) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 333(d)), as amended by subsection 
(b), is further amended by adding at the end the following:
            ``(3)(A) No person shall be subject to the penalties of 
        subsection (a)(1) for a violation of subsection (a), (b), or 
        (c) of section 301 involving food that is misbranded within the 
        meaning of section 403(z) if--
                    ``(i) such person is an agricultural producer and 
                the violation occurs because food that is grown, 
                raised, or otherwise produced by such producer, which 
                food does not contain a genetically engineered material 
                and was not produced with a genetically engineered 
                material, is contaminated with a food that contains a 
                genetically engineered material or was produced with a 
                genetically engineered material; and
                    ``(ii) such contamination is not intended by the 
                agricultural producer.
            ``(B) Subparagraph (A) does not apply to an agricultural 
        producer to the extent that the contamination occurs as a 
        result of the negligence of the producer.''.
    (d) Promulgation of Regulations.--Not later than 1 year after the 
date of enactment of this Act, the Secretary shall promulgate proposed 
regulations establishing labeling requirements for compliance in 
accordance with section 403(z) of the Federal Food, Drug, and Cosmetic 
Act, as added by subsection (a).
Example Output: Genetically Engineered Food Right-to-Know Act - Amends the Federal Food, Drug, and Cosmetic Act to deem misbranded any food that has been genetically engineered or contains one or more genetically engineered ingredients, unless such information is clearly disclosed. Exempts from this requirement any food that: (1) is served in restaurants or other similar eating establishments, (2) is a medical food, (3) would be subject to such requirement solely because it was produced using a genetically engineered vaccine, or (4) would be subject to such requirement solely because it includes the use of a genetically engineered processing aid (including yeast) or enzyme. Defines &quot;genetically engineered&quot; as a material intended for human consumption that is: (1) an organism produced through the intentional use of genetic engineering, or (2) the progeny of intended sexual or asexual reproduction (or both) of one or more organisms that is the product of genetic engineering. Defines &quot;genetically engineered ingredient&quot; as an ingredient in a food that is derived from any part of an organism that has been genetically engineered, without regard to whether: (1) the altered molecular or cellular characteristics of the organism are detectable in the material, and (2) the organism is capable for use as human food. Excludes from penalties for misbranding of genetically engineered food or ingredients any recipient that establishes a guaranty or undertaking that: (1) is signed by, and contains the name and address of, a person residing in the United States from whom the recipient received the food in good faith (including the receipt of seeds to grow raw agricultural commodities); and (2) contains a statement to the effect that the food is not genetically engineered or does not contain a genetically engineered ingredient. Applies this exclusion from penalties without regard to the manner in which the recipient uses the food. Excludes an agricultural producer also from such penalties when a violation occurs because food the producer has grown, raised, or otherwise produced, which neither contains nor was produced with a genetically engineered material, is subsequently contaminated with a food that does contain or was produced with a genetically engineered material, and the agricultural producer has not intended any such contamination nor was negligent in the matter.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``China Fair Trade Act of 2010''.

SEC. 2. RECIPROCAL COMPETITIVE TRADE PRACTICES.

    (a) In General.--Section 302(a)(2) of the Trade Agreements Act of 
1979 (19 U.S.C. 2512(a)(2)) is amended to read as follows:
            ``(2) Exceptions.--
                    ``(A) In general.--Paragraph (1) shall not apply in 
                the case of procurements for which--
                            ``(i) there are no offers of products or 
                        services of the United States or of eligible 
                        products; or
                            ``(ii) the offers of products or services 
                        of the United States or of eligible products 
                        are insufficient to fulfill the requirements of 
                        the United States Government.
                    ``(B) Special rule with respect to the people's 
                republic of china.--Subparagraph (A) shall not apply in 
                the case of procurements of products or services of the 
                People's Republic of China.''.
    (b) Waiver.--Section 302(b) of the Trade Agreements Act of 1979 (19 
U.S.C. 2512(b)) is amended in the matter preceding paragraph (1), by 
inserting ``, except in the case of the People's Republic of China,'' 
before ``may''.

SEC. 3. REQUIREMENTS TO BUY CERTAIN ITEMS FROM AMERICAN SOURCES.

    (a) Buy American Act.--
            (1) American materials required for public use.--Section 
        2(a) of the Buy American Act (41 U.S.C. 10a(a)) is amended by 
        inserting after the second sentence the following: ``The 
        exceptions in the previous two sentences shall not apply with 
        respect to articles, materials, or supplies mined, produced, or 
        manufactured, as the case may be, in the People's Republic of 
        China until such time as China becomes a party to the Agreement 
        on Government Procurement (described in section 101(d)(17) of 
        the Uruguay Round Agreements Act (19 U.S.C. 3511(d)(17)).''.
            (2) Contract specifications.--Section 3(a) of the Buy 
        American Act (41 U.S.C. 10b(a)) is amended by striking 
        ``exception.'' and inserting ``exception: Provided further, 
        That such an exception may not permit the use of articles, 
        materials, or supplies mined, produced, or manufactured, as the 
        case may be, in the People's Republic of China until such time 
        as China becomes a party to the Agreement on Government 
        Procurement (described in section 101(d)(17) of the Uruguay 
        Round Agreements Act (19 U.S.C. 3511(d)(17)).''.
            (3) Reports.--Section 2(b)(2)(A) of the Buy American Act 
        (41 U.S.C. 10a(b)(2)(A)) is amended by inserting before the 
        semicolon the following: ``and the country in which such 
        articles, materials, or supplies were manufactured''.
    (b) Defense Contracts for Certain Articles.--Section 2533a of title 
10, United States Code, is amended by adding at the end the following 
new subsection:
    ``(l) Inapplicability of Exceptions to Articles From the People's 
Republic of China.--The exceptions to the requirement in subsection (a) 
provided under subsections (c) through (h) shall not apply with respect 
to items grown, reprocessed, reused, or produced in the People's 
Republic of China until such time as China becomes a party to the 
Agreement on Government Procurement (described in section 101(d)(17) of 
the Uruguay Round Agreements Act (19 U.S.C. 3511(d)(17)).''.
    (c) Requirements To Use American Iron, Steel, and Manufactured 
Goods Under the American Recovery and Reinvestment Act of 2009.--
Section 1605 of the American Recovery and Reinvestment Act of 2009 
(Public Law 111-5; 123 Stat. 303) is amended by adding at the end the 
following new subsection:
    ``(e) The exceptions in subsection (b) shall not apply with respect 
to iron, steel, and manufactured goods from the People's Republic of 
China until such time as China becomes a party to the Agreement on 
Government Procurement (described in section 101(d)(17) of the Uruguay 
Round Agreements Act (19 U.S.C. 3511(d)(17)).''.

SEC. 4. REPORT ON PRODUCTIVE CAPACITY OF THE PEOPLE'S REPUBLIC OF 
              CHINA.

    (a) In General.--Not later than 180 days, the Secretary of Commerce 
shall submit to Congress a report on the productive capacity of the 
major industrial sectors in the People's Republic of China.
    (b) Contents.--The report required by subsection (a) shall include 
an assessment of any steps taken by the Government of the People's 
Republic of China to develop, expand, retract, or otherwise alter the 
productive capacity of the sectors identified in the report.

SEC. 5. REPORT ON SUBSIDIES PROVIDED BY THE PEOPLE'S REPUBLIC OF CHINA 
              FOR RENEWABLE ENERGY PRODUCTS AND TECHNOLOGY.

    (a) Report.--Not later than 180 days after the date of the 
enactment of this Act, the Secretary of Energy, in consultation with 
other appropriate agencies, shall report to Congress regarding the 
policies of the Government of the People's Republic of China with 
respect to, and the subsidies provided by the People's Republic of 
China for, the development and exportation of renewable energy products 
and technologies. The report shall include an analysis of the impact of 
the policies and subsidies on United States manufacturers of renewable 
energy products and technologies.
    (b) Definitions.--
            (1) Renewable energy.--The term ``renewable energy'' means 
        energy generated by a renewable energy resource.
            (2) Renewable energy product or technology.--The term 
        ``renewable energy product or technology'' means any product, 
        technology, or component of a product used in the development 
        or production of renewable energy.
            (3) Renewable energy resource.--The term ``renewable energy 
        resource'' means--
                    (A) solar, wind, ocean, tidal, hydrokinetic, or 
                geothermal energy;
                    (B) biofuel, biomass, or hydropower; or
                    (C) any other renewable energy resource, as 
                determined by the Secretary of Energy.
Example Output: China Fair Trade Act of 2010 - Amends the Trade Agreements Act of 1979 to provide that certain exceptions and waivers to the prohibition on the procurement of the products of a country that is not a party to the Agreement on Government Procurement shall not apply with respect to the procurements of products or services of the People's Republic of China.

Amends the Buy American Act to declare that certain exceptions to the Act requiring only U.S. materials be used for public use shall not apply to the procurement of Chinese made products until China becomes a party to the Agreement.

Declares that certain exceptions to Buy American requirements shall not apply to the procurement of Chinese products by the Department of Defense (DOD) until China becomes a party to such Agreement.

Amends the American Recovery and Reinvestment Act of 2009 to declare that certain exceptions to Buy American requirements under such Act shall not apply to the procurement of Chinese steel and products until China becomes a party to the Agreement.

Requires the Secretary of Commerce to report to Congress on the productive capacity of the major industrial sectors in China.

Directs the Secretary of Energy to report to Congress on: (1) Chinese policies and the subsidies China provides in the development and exportation of renewable energy products and technologies; and (2) the impact such policies and subsidies have on U.S. manufacturers of such products and technologies.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ethical Stem Cell Research Tax 
Credit Act of 2008''.

SEC. 2. CREDIT FOR ETHICAL STEM CELL RESEARCH.

    (a) In General.--Subpart D of part IV of subchapter A of chapter 1 
(relating to business related credits) of the Internal Revenue Code of 
1986 is amended by adding at the end the following new section:

``SEC. 45O. ETHICAL STEM CELL RESEARCH.

    ``(a) Allowance of Credit.--For purposes of section 38, in the case 
of an eligible taxpayer, the ethical stem cell research credit 
determined under this section for the taxable year shall be an amount 
equal to 30 percent of the qualified stem cell research expenses paid 
or incurred by the taxpayer during the taxable year.
    ``(b) Eligible Taxpayer.--For purposes of this section, the term 
`eligible taxpayer' means any taxpayer that elects the application of 
this section for the taxable year.
    ``(c) Qualified Stem Cell Research Expenses.--For purposes of this 
section--
            ``(1) In general.--The term `qualified stem cell research 
        expenses' means expenses which are paid or incurred by the 
        eligible taxpayer during the taxable year in carrying on basic 
        and applied research to develop techniques for the isolation, 
        derivation, production, testing, and human clinical use of stem 
        cells that may result in improved understanding of or 
        treatments for diseases and other adverse health conditions, no 
        part of which may involve--
                    ``(A) the creation of a human embryo for research 
                purposes,
                    ``(B) the destruction of or discarding of, or risk 
                of injury to, a human embryo, or
                    ``(C) the use of any stem cell, the derivation or 
                provision of which would be inconsistent with 
                subparagraph (A) or (B).
            ``(2) Human embryo.--The term `human embryo' means any 
        organism not protected as a human subject under part 46 of 
        title 45, Code of Federal Regulations (as in effect on the date 
        of the enactment of this section) that is derived by 
        fertilization, parthenogenesis, cloning, or any other means 
        from one or more human gametes or human diploid cells.
            ``(3) Risk of injury.--The term `risk of injury' means 
        subjecting a human embryo to risk of injury or death greater 
        than that allowed for research on a fetus in utero under 
        section 498(b) of the Public Health Service Act (42 U.S.C. 
        289g(b)) (as in effect on the date of the enactment of this 
        section) and section 46.204(b) of title 45, Code of Federal 
        Regulations (as so in effect).
    ``(d) Treatment of Qualified Stem Cell Research Expenses.--
            ``(1) In general.--Except as provided in paragraph (2), any 
        qualified stem cell research expenses for a taxable year to 
        which an election under this section applies shall not be taken 
        into account for purposes of determining the credit allowable 
        under section 41 for such taxable year.
            ``(2) Treated as base period research expenses.--Any 
        qualified stem cell research expenses for any taxable year 
        which are qualified research expenses (within the meaning of 
        section 41(b)) shall be taken into account in determining base 
        period research expenses for purposes of applying section 41 to 
        subsequent taxable years.
    ``(e) Special Rules.--
            ``(1) Limitation.--No credit shall be allowed under this 
        section with respect to any stem cell research conducted by a 
        corporation to which an election under section 936 applies.
            ``(2) Aggregation of expenditures and allocations of 
        credit.--Rules similar to the rules of paragraphs (1) and (2) 
        of section 41(f) and section 41(g) shall apply for purposes of 
        this section.''.
    (b) Credit Allowed as Part of General Business Credit.--Section 
38(b) of the Internal Revenue Code of 1986 is amended by striking 
``plus'' at the end of paragraph (30), by striking the period at the 
end of paragraph (31) and inserting ``, plus'', and by adding at the 
end the following new paragraph:
            ``(32) the ethical stem cell research credit determined 
        under section 45O(a).''.
    (c) Denial of Double Benefit.--Section 280C of the Internal Revenue 
Code of 1986 is amended by adding at the end the following new 
subsection:
    ``(f) Ethical Stem Cell Research Credit.--
            ``(1) In general.--No deduction shall be allowed for that 
        portion of the qualified stem cell research expenses (as 
        defined in section 45O(c)(1)) otherwise allowable as a 
        deduction for the taxable year which is equal to the amount of 
        the credit determined for such taxable year under section 
        45O(a).
            ``(2) Similar rule where taxpayer capitalizes rather than 
        deducts expenses.--If--
                    ``(A) the amount of the credit determined for the 
                taxable year under section 45O(a), exceeds
                    ``(B) the amount allowable as a deduction for such 
                taxable year for qualified stem cell research expenses 
                (determined without regard to paragraph (1)),
        the amount chargeable to capital account for the taxable year 
        for such expenses shall be reduced by the amount of such 
        excess.
            ``(3) Controlled groups.--Paragraph (3) of subsection (b) 
        shall apply for purposes of this subsection.''.
    (d) Clerical Amendment.--The table of sections for subpart D of 
part IV of subchapter A of chapter 1 of the Internal Revenue Code of 
1986 is amended by adding at the end the following new item:

``Sec. 45O. Ethical stem cell research.''.
    (e) Effective Date.--The amendments made by this section shall 
apply to amounts paid or incurred after the date of the enactment of 
this Act.
Example Output:
Ethical Stem Cell Research Tax Credit Act of 2008 - Amends the Internal Revenue Code to allow a tax credit for 30% of qualified stem cell research expenses paid or incurred in a taxable year. Defines "qualified stem cell research expenses" as expenses for carrying out basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of or treatments for diseases and other adverse health conditions. Prohibits a tax credit for any research expenses that may involve: (1) the creation of a human embryo for research purposes; (2) the destruction of or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell for prohibited purposes.